Professional Role and Current Position
Reid Linn serves as Vice President and Chief Data Science Officer at PathGroup, Inc., a provider of pathology and clinical laboratory services based in the Nashville Metropolitan Area. He holds the title of AVP, Chief Data Science Officer, a role he has occupied since joining PathGroup initially in 2011 with a noted tenure starting in July 2018 as AVP. His responsibilities center on leading data science initiatives within the organization, focusing on strategic analytics and operational insights that likely impact laboratory diagnostics, molecular pathology, and precision medicine services.
Career History and Expertise
Prior to his tenure at PathGroup, Reid Linn was Director of Strategic Analytics at Broadcast Music, Inc. (BMI) starting in 2009, where he developed expertise in analytics leadership. His transition from music industry analytics to healthcare labs signals a strong versatility in managing complex data-driven decision-making environments.
His educational background includes studies at William & Mary, which supports a foundation relevant to his applied analytics and leadership capabilities.
Location and Professional Network
Reid is based in the Nashville, Tennessee Metropolitan Area, a key regional hub for healthcare and biotechnology industries, supporting accessibility to PathGroup’s operational centers and industry networks. He maintains an active professional presence with over 500+ LinkedIn connections, indicating broad industry engagement.
Company Context: PathGroup, Inc.
PathGroup is an established pathology and laboratory services company offering specialized molecular pathology and diagnostics. The executive team, including Reid Linn, is rated relatively low by employee feedback platforms, with a reported 2.5/5 rating on Comparably reflecting potential internal challenges or employee sentiment concerns. The CEO is Ben Davis, under whose leadership the executive team (with Linn as a key data science executive) manages the company’s technological and clinical data strategies.
PathGroup emphasizes innovation in regulated tissue diagnostics and is involved in advancing clinical insight, speed of results, and health economics through sophisticated data science applications — areas directly aligned with Linn’s leadership in data science.
Relevance of Expertise to Industry Trends
Given the integration of molecular diagnostics and tissue analytics in PathGroup’s service offerings, Reid Linn’s role is critical in driving the company’s competitive edge through data science, analytics, and strategic innovation. His previous leadership in strategic analytics and longevity at PathGroup positions him as a key decision-maker in evaluating technologies and partnerships that enhance lab efficiency, quality of insights, and cost-effectiveness.
Additional Observations
- There is no publicly available detailed record of specific publications, patents, or conference presentations by Reid Linn, suggesting his work may be largely internal or proprietary in nature.
- PathGroup’s focus on molecular pathology and its commitment to developing innovative regulated tissue portfolios indicates ongoing strategic initiatives where data science optimization, which Linn leads, is pivotal.
- Reid Linn’s time spent at Broadcast Music, Inc. as a strategic analytics director suggests a strong background in data-centric decision frameworks, which are transferable to the healthcare lab environment where PathGroup operates.
This profile provides a detailed understanding of Reid Linn’s leadership function in data science at PathGroup, highlighting his strategic analytics background, role in healthcare diagnostics innovation, and the company’s position within the healthcare services market.
